Please ensure Javascript is enabled for purposes of website accessibility

Tag Archives: glaxosmithkline

Human Genome Sciences enters talks with potential suitors

Human Genome Sciences Inc. entered into confidentiality agreements with “certain parties” and is providing an opportunity to engage in due diligence reviews, the Rockville-based company said Thursday. Its board of directors unanimously said shareholders should reject an “inadequate” $2.6 billion ...

Read More »

Human Genome rejects GlaxoSmithKline’s $2.59B bid (access required)

The decision by Rockville-based biotech drugmaker Human Genome Sciences Inc. to reject an unsolicited $2.59 billion takeover bid Thursday may increase the eventual sale price of the company, analysts said. The question is by how much. “For the most part, ...

Read More »

Novartis to pay $99M to settle overtime lawsuit

A U.S. division of Swiss drugmaker Novartis AG says it will pay $99 million to settle a class-action lawsuit about overtime pay for U.S. sales representatives. Attorney David Sanford says the case involves about 7,700 current and former sales representatives ...

Read More »

Rockville-based Human Genome Sciences gets approval for new lupus drug

Benlysta, a drug to treat lupus, has received approval from European regulators to be marketed in Europe, the drug’s co-makers, Human Genome Sciences Inc. of Rockville, and GlaxoSmithKline, its London-based parent, announced. The European approval came two days after Benlysta, ...

Read More »

Denis King and Gary Ronan: What to do when the government comes calling (access required)

What to do when the government comes calling. It’s a topic of frequent discussion among both in-house and outside counsel, one that took on heightened significance with the prosecution of a former GlaxoSmithKline lawyer in U.S. District Court in Baltimore ...

Read More »

Prosecutor: Former GlaxoSmithKline lawyer went too far (access required)

To federal prosecutors, former GlaxoSmithKline attorney Lauren Stevens led an effort to obstruct a U.S. Food and Drug Administration probe into her company’s marketing of the anti-depressant Wellbutrin SR as a weight-loss drug, a use not approved by the FDA. ...

Read More »

Month-long trial expected for former GlaxoSmithKline lawyer (access required)

Opening arguments begin Wednesday in the trial of a former GlaxoSmithKline attorney on charges of obstructing a U.S. Food and Drug Administration probe into her company’s marketing of the anti-depressant Wellbutrin SR as a weight-loss drug, a use not approved ...

Read More »